C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
11/2004
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235944 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
11/25/2004	US20040235943 Triptolide derivatives for modulation of apoptosis and immunosuppression
11/25/2004	US20040235939 Macrolactone having very dense functionalization; antiproliferative activity
11/25/2004	US20040232383 Isosorbide derivatives
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478356A2 Therapeutic compounds
11/24/2004	EP0954374B1 Adsorbens and devices for the reduction of small organic compounds from blood products
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1548439A Prepn of racemized and optically active poon essence A and its analog
11/24/2004	CN1176917C Prep. of pyrone compound
11/24/2004	CN1176914C Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives
11/18/2004	WO2004099216A2 Syntheses of podophyllotoxin from desoxypodophyllotoxin
11/18/2004	WO2004099135A2 Hiv prodrugs cleavable by cd26
11/18/2004	WO2004098644A1 Prodrugs cleavable by cd26
11/18/2004	US20040230064 Novel labeled resiniferatoxin derivatives
11/18/2004	US20040230062 reacting androstane-3-one derivative with ozone
11/18/2004	CA2525191A1 Prodrugs cleavable by cd26
11/18/2004	CA2517338A1 Hiv prodrugs cleavable by cd26
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1054994B1 Fermentative preparation process for cytostatics and crystal forms thereof
11/17/2004	CN1546494A Tricycloacetal lactones ,preparing process and use thereof
11/17/2004	CN1546493A Synthesis method for preparation of psoralen
11/16/2004	US6818781 Dehydration of sugar alcohols; separation; foods, drugs
11/16/2004	US6818779 Thromboxane ligands without blood clotting side effects
11/16/2004	US6818649 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/16/2004	US6818044 Process for recovery of subliming substance
11/11/2004	WO2004078875A3 Novel dyes and use thereof in imaging members and methods
11/11/2004	WO2004075853A9 Halogenated triptolide derivatives as immunomodulators and anticancer agents
11/11/2004	WO2004014849A3 Isosorbide mononitrate compositions and methods of their use
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224936 Macrocyclic compounds useful as pharmaceuticals
11/11/2004	US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors
11/10/2004	EP1475382A1 Compounds as semaphorin inhibitors
11/10/2004	EP1237562B1 Process for preparing mikania extracts containing mikanolide and dihydromikanolide and use in the treatment of proliferative disorders
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545511A Rapamycin 29-enols
11/10/2004	CN1545508A 1,2,4-trioxolane antimalarials
11/10/2004	CN1544437A Desugar and deaminosugar FR-008 derived polyketone antibiotics
11/10/2004	CN1544436A Process for the preparation of epothilone a and b n-oxides and the products obtained thereby
11/10/2004	CN1543945A Medicine and technique for monomer extraction from psoralea fruit
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	CA2278139C Novel photochromic heterocyclic fused indenonaphthopyrans
11/04/2004	WO2004094647A2 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	WO2004094400A2 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004	WO2004078874A3 Novel dye complexes and use thereof in imaging members and methods
11/04/2004	US20040220251 Furanose-type bicyclic carbohydrates with biological activity
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040219564 DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
11/04/2004	US20040219538 DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
11/04/2004	CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	CA2518819A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/03/2004	EP1472536A2 Broad spectrum inhibitors
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472239A1 Method for the preparation of enterolactone from matairesinol
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472206A1 Lignan derivatives
11/03/2004	EP1292275A4 Ferulic ester derivative, 3,9-diferulylcoumestrol and cosmetic product containing same
11/03/2004	EP1228087A4 Antibody catalysis of enantio- and diastereo-selective aldol reactions
11/03/2004	CN1543466A New use of specific cyclolignans
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/03/2004	CN1173724C Systemic separation process and preparation of gingkgo leaf extract
11/02/2004	US6812245 Polycylic xanthones and their use
11/02/2004	US6812213 Steroidal sapogenins and their derivatives for treating alzheimer's disease
10/2004
10/28/2004	WO2004092180A1 Flavone derivatives, process for producing them, and drugs containing the same
10/28/2004	WO2004092179A1 Spiro derivative, production process, and antioxidant
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004078479A3 Imaging system
10/28/2004	WO2004078030A3 Rhodol derivatives useful as image dyes
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	US20040214871 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester
10/28/2004	US20040214847 Anti-first-pass effect compounds
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/27/2004	EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor
10/27/2004	EP1471062A1 Fullerene epoxide and process for producing the same
10/27/2004	EP1248788B1 Synthesis of isosorbide mononitrate
10/27/2004	CN1539831A Taxad alkyl derivative and its prepn. process
10/27/2004	CN1172917C Steroid receptor modulator compounds and methods
10/26/2004	US6809176 Compounds for use in treatment of cancer
10/26/2004	US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects
10/26/2004	US6808762 Oxabicyclooctanes
10/21/2004	WO2004089956A1 Novel amino acid dysiherbaine
10/21/2004	WO2004089926A2 Genipin derivatives and uses thereof
10/21/2004	WO2004073375A8 Podophyllotoxin derivatives as antitumor agents
10/21/2004	US20040209825 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto
10/20/2004	EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators
10/20/2004	CN1538952A Protected 3,5-dihydroxy-2, 2-dimethyl-valeroamides for synthesis of epothilone and derivatives and method for production and use thereof
10/20/2004	CN1537856A Anti-first-pass effect compounds
10/20/2004	CN1537855A Hypoxylonin and its preparation method and application
10/20/2004	CN1171890C Prepn process and plant of high-purity eudesmin
10/19/2004	US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004	US6806025 Photoresist monomers, polymers thereof and photoresist compositons containing the same
10/19/2004	CA2168843C Thermodynamically stable crystal form of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b benzoic acid salt and processes for its preparation
10/14/2004	WO2004088422A1 Fluoro compound and fluoropolymer
10/14/2004	WO2004087687A1 Chromene derivatives as anti-inflammatory agents

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 174